{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:00Z","timestamp":1791862200559,"version":"4.3.4"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260657-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Puberty blockers are an established, reversible intervention for central precocious puberty in children and gender dysphoria in adolescents. Despite broad clinical support, these treatments are currently politically contested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260657-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the mental health of transgender youths prescribed puberty blockers compared with cisgender peers who received these medications for treatment of precocious puberty and with transgender and cisgender youths who did not receive these medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260657-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study used data from a US nationwide, multipayer claims database from January 2016 to January 2025. Youths aged 10 to 17 years were categorized into 4 cohorts based on gender modality (transgender or cisgender) and prescription of a puberty blocker (yes or no).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260657-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Primary outcomes were\n                      <jats:italic toggle=\"yes\">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">ICD-10<\/jats:italic>\n                      ) diagnoses of mood disorders and suicidal thoughts and behaviors. Inverse probability\u2013weighted generalized estimating equation models were fit to obtain adjusted odds ratios (aORs) and 95% CIs, adjusting for demographics, payer type, region, year, socioeconomic disadvantage, and policy environment indices. In demographics,\n                      <jats:italic toggle=\"yes\">female gender marker<\/jats:italic>\n                      is used to indicate that an\n                      <jats:italic toggle=\"yes\">F<\/jats:italic>\n                      (female) has been applied as a marker for the individual by some entity (eg, a medical professional or government body).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260657-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 231\u202f783 youths in the analytical sample, 41\u202f472 youths (17.89%) were transgender (median [IQR] age at baseline, 9.00 [7.00-11.00] years; 31\u202f246 with female gender marker [75.34%]) and 190\u202f311 youths (82.11%) were cisgender (median [IQR] age at baseline, 8.00 [6.00-10.00] years; 128\u202f942 with female gender marker [67.75%]). Being transgender was associated with higher odds of mood disorder diagnosis (aOR, 4.42 [95% CI, 4.24-4.60]) and suicidal thoughts and behaviors (aOR, 12.21 [95% CI, 10.69-13.95]) compared with being cisgender. Being prescribed a puberty blocker was associated with higher odds of mood disorder diagnosis (aOR, 2.11 [95% CI, 2.02-2.19]) and suicidal thoughts and behaviors (aOR, 3.04 [95% CI, 2.65-3.49]) compared with no prescription. However, among transgender youths, prescription of a puberty blocker was associated with decreased adjusted odds of mood disorder diagnosis (aOR, 0.52 [95% CI, 0.45-0.60]) and suicidal thoughts and behaviors (aOR, 0.20 [95% CI, 0.14-0.29]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260657-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, transgender youths overall had substantially higher rates of diagnosed mood disorder and suicidal thoughts and behaviors than their cisgender peers, highlighting the need for population-specific interventions. Prescription of a puberty blocker was associated with partial attenuation of this disparity, suggesting mental health benefits associated with this treatment for transgender youth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.23302","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:30:27Z","timestamp":1784302227000},"page":"e2623302","source":"Crossref","is-referenced-by-count":1,"title":["Mental Health of Youths Who Use Puberty Blockers"],"prefix":"10.1001","volume":"9","author":[{"given":"Clair","family":"Kronk","sequence":"first","affiliation":[{"name":"Institute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Jain","sequence":"additional","affiliation":[{"name":"Institute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[{"name":"Institute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hill L.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Hughes","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Boston, Massachusetts"},{"name":"Department of Population Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy G.","family":"Goetz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pennsylvania, Philadelphia"},{"name":"Now with Department of Psychiatry, Mid-Atlantic Permanente Medical Group, Upper Marlboro, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Psychology, St John\u2019s University, Queens, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Hardy","sequence":"additional","affiliation":[{"name":"Independent researcher, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie","family":"Kidd","sequence":"additional","affiliation":[{"name":"West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari L.","family":"Reisner","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor"},{"name":"Center for Social Epidemiology and Population Health, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"zoi260657r1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.annepidem.2024.05.004","article-title":"Disparities in behaviors and experiences among transgender and cisgender high school students\u201418 U.S. states, 2021.","volume":"94","author":"Suarez","year":"2024","journal-title":"Ann Epidemiol"},{"key":"zoi260657r2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.720681","article-title":"Examining mental health differences between transgender, gender nonconforming, and cisgender young people in British Columbia.","volume":"12","author":"Pattison","year":"2021","journal-title":"Front Psychiatry"},{"issue":"8","key":"zoi260657r3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1111\/j.1743-6109.2010.01943.x","article-title":"Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.","volume":"8","author":"de Vries","year":"2011","journal-title":"J Sex Med"},{"key":"zoi260657r5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/jcrpe.2017.S004","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty.","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2","key":"zoi260657r7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/26895269.2020.1747768","article-title":"Is puberty delaying treatment \u2018experimental treatment\u2019?","volume":"21","author":"Giordano","year":"2020","journal-title":"Int J Transgend Health"},{"issue":"3","key":"zoi260657r8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/00918369.2012.653300","article-title":"Clinical management of gender dysphoria in children and adolescents: the Dutch approach.","volume":"59","author":"de Vries","year":"2012","journal-title":"J Homosex"},{"issue":"3","key":"zoi260657r9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamapediatrics.2024.6081","article-title":"Gender-affirming medications among transgender adolescents in the US, 2018-2022.","volume":"179","author":"Hughes","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"2","key":"zoi260657r10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1725","article-title":"Pubertal suppression for transgender youth and risk of suicidal ideation.","volume":"145","author":"Turban","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"zoi260657r11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2162","article-title":"Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents.","volume":"142","author":"Rafferty","year":"2018","journal-title":"Pediatrics"},{"issue":"11","key":"zoi260657r12","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline.","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi260657r14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"issue":"3","key":"zoi260657r15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/jamia\/ocad247","article-title":"OHDSI Standardized Vocabularies\u2014a large-scale centralized reference ontology for international data harmonization.","volume":"31","author":"Reich","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"20","key":"zoi260657r17","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1002\/sim.1241","article-title":"Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random.","volume":"21","author":"Preisser","year":"2002","journal-title":"Stat Med"},{"issue":"429","key":"zoi260657r18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/01621459.1995.10476494","article-title":"Semiparametric efficiency in multivariate regression models with missing data.","volume":"90","author":"Robins","year":"1995","journal-title":"J Am Stat Assoc"},{"issue":"404","key":"zoi260657r19","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values.","volume":"83","author":"Little","year":"1988","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"zoi260657r21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15585\/mmwr.su7304a6","article-title":"Disparities in school connectedness, unstable housing, experiences of violence, mental health, and suicidal thoughts and behaviors among transgender and cisgender high school students\u2014Youth Risk Behavior Survey, United States, 2023.","volume":"73","author":"Suarez","year":"2024","journal-title":"MMWR Suppl"},{"issue":"1","key":"zoi260657r22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.psychres.2014.12.045","article-title":"Dissociative symptoms in individuals with gender dysphoria: is the elevated prevalence real?","volume":"226","author":"Colizzi","year":"2015","journal-title":"Psychiatry Res"},{"issue":"1","key":"zoi260657r23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/trgh.2019.0029","article-title":"Mental health diagnoses among transgender patients in the clinical setting: an all-payer electronic health record study.","volume":"4","author":"Wanta","year":"2019","journal-title":"Transgend Health"},{"key":"zoi260657r24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jad.2020.05.074","article-title":"Increased prevalence of depression, anxiety, and adjustment and somatoform disorders in transsexual individuals.","volume":"274","author":"Konrad","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi260657r25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/brainsci12030366","article-title":"Substance use in the transgender population: a meta-analysis.","volume":"12","author":"Cotaina","year":"2022","journal-title":"Brain Sci"},{"issue":"4","key":"zoi260657r26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jadohealth.2018.07.006","article-title":"Minority stress factors associated with depression and anxiety among transgender and gender-nonconforming youth.","volume":"64","author":"Chodzen","year":"2019","journal-title":"J Adolesc Health"},{"key":"zoi260657r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2021.102113","article-title":"Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: systematic review and meta-analysis.","volume":"91","author":"Pellicane","year":"2022","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"zoi260657r28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev-clinpsy-072220-020326","article-title":"Mental health of transgender and gender diverse youth.","volume":"19","author":"Wittlin","year":"2023","journal-title":"Annu Rev Clin Psychol"},{"issue":"6","key":"zoi260657r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.16679","article-title":"Central precocious puberty and psychiatric disorders.","volume":"8","author":"Dinkelbach","year":"2025","journal-title":"JAMA Netw Open"},{"key":"zoi260657r30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coemr.2020.04.003","article-title":"Psychosexual effects resulting from delayed, incomplete, or absent puberty.","volume":"14","author":"Dwyer","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"4","key":"zoi260657r31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/20476965.2019.1581433","article-title":"Key considerations when using health insurance claims data in advanced data analyses: an experience report.","volume":"9","author":"Konrad","year":"2019","journal-title":"Health Syst (Basingstoke)"},{"issue":"2","key":"zoi260657r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0978","article-title":"Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care.","volume":"5","author":"Tordoff","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi260657r33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jadohealth.2021.10.036","article-title":"Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth.","volume":"70","author":"Green","year":"2022","journal-title":"J Adolesc Health"},{"issue":"1","key":"zoi260657r35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/07435584221100591","article-title":"Experiences of puberty and puberty blockers: insights from trans children, trans adolescents, and their parents.","volume":"39","author":"Horton","year":"2024","journal-title":"J Adolesc Res"},{"issue":"3","key":"zoi260657r36","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.jadohealth.2023.11.299","article-title":"101. Experiences of transgender youth with puberty suppression in a pediatric hospital-based gender clinic: a qualitative study.","volume":"74","author":"Hobson","year":"2024","journal-title":"J Adolesc Health"},{"key":"zoi260657r6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-94-009-0725-6_5","volume-title":"GnRH Analogues in Cancer and Human Reproduction","author":"Kauli","year":"1990"},{"key":"zoi260657r4","unstructured":"Conron? KJ, O\u2019Neill? K, Vasquez? LA, Mallory? C. Prohibiting gender-affirming medical care for youth: brief\/March 2022. Williams Institute. 2022. Accessed July 16, 2024. https:\/\/williamsinstitute.law.ucla.edu\/wp-content\/uploads\/Trans-Youth-Health-Bans-Mar-2022.pdf"},{"key":"zoi260657r13","unstructured":"The Pediatric Endocrine Society opposes bills that harm transgender youth. Published online April 2021. Accessed November 24, 2025. https:\/\/pedsendo.org\/wp-content\/uploads\/2021\/04\/The-Pediatric-Endocrine-Society-Statement-TG.pdf"},{"key":"zoi260657r16","unstructured":"Robert Graham Center. Social deprivation index (SDI). Published online May 16, 2026. Accessed June 15, 2026. https:\/\/www.graham-center.org\/evidence-based-research\/featured-work\/social-deprivation-index"},{"key":"zoi260657r20","doi-asserted-by":"crossref","unstructured":"Hellen? NWT. Package \u201cmissr\u201d: classify missing data as MCAR, MAR, or MNAR. July 22, 2025. Accessed June 5, 2026. https:\/\/cran.r-project.org\/web\/packages\/missr\/missr.pdf","DOI":"10.32614\/CRAN.package.missr"},{"key":"zoi260657r34","unstructured":"Lott-Lavigna? R. \u201cI cried\u201d: young trans people on the move to block hormone treatment. December 2, 2020. Accessed November 10, 2025. https:\/\/www.vice.com\/en\/article\/i-cried-young-trans-people-on-the-move-to-block-puberty-blockers\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851743\/kronk_2026_oi_260657_1783701529.87048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:30:28Z","timestamp":1784302228000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.23302","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}